| Bioactivity | Cisplatin-resistant cells-IN-1 (Compound 8) has high cytotoxicity against Cisplatin (HY-17394)-resistant cells. Cisplatin-resistant cells-IN-1 reduces the metabolic activity effectively in the low nanomolar range (IC50: 0.14–1.79 μM in A549/A549-R, K562/K562-R, and MCF-7/MCF-7TamR cells)[1]. |
| Name | Cisplatin-resistant cells-IN-1 |
| Formula | C38H40AuF6N4P- |
| Molar Mass | 894.68 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Paul Kapitza, et al. Reaction Behavior of [1,3-Diethyl-4,5-diphenyl-1H-imidazol-2-ylidene] Containing Gold(I/III) Complexes against Ingredients of the Cell Culture Medium and the Meaning on the Potential Use for Cancer Eradication Therapy. J. Med. Chem. 2023, 66, 12, 8238–8250. |
Cisplatin-resistant cells-IN-1
CAS: F: C38H40AuF6N4P- W: 894.68
Cisplatin-resistant cells-IN-1 (Compound 8) has high cytotoxicity against Cisplatin (HY-17394)-resistant cells. Cisplati
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.